Trials / Active Not Recruiting
Active Not RecruitingNCT04302454
Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The overall aim of this project is to test the hypothesis that the addition of ADT to metastasis-directed radiotherapy (MDRT) in well-selected PCa patients with oligo-metastatic disease prolongs the metastases progression-free survival (MPFS) compared to MDRT alone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radiotherapy | Radiotherapy |
| DRUG | Leuprorelin | Hormonal therapy |
Timeline
- Start date
- 2020-03-19
- Primary completion
- 2027-10-21
- Completion
- 2027-12-01
- First posted
- 2020-03-10
- Last updated
- 2025-04-04
Locations
13 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04302454. Inclusion in this directory is not an endorsement.